Latest Renal Transplant Research News From Glickman Urological & Kidney Institute

From the Medical Editors of Cleveland Clinic’s Research Notes: Kidney Transplant

By Emilio Poggio, MD, and David Goldfarb, MD

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

At the Glickman Urological & Kidney Institute’s Center for Renal Transplantation, the pursuit of groundbreaking scientific discoveries leading to improved care for patients in need of kidney transplants leverages critical collaborative research interactions among clinicians, educators and scientists within our organization. It is a true multidisciplinary effort.

In Research Notes: Kidney Transplant we highlight some of our recent scientific initiatives that will positively impact the transplantation community. Our research is broadly focused, ranging from basic projects that provide unique insight into disease mechanisms to the analysis of national population registries that help us understand administrative and clinical outcomes extending beyond our transplant center.

  • Robert Fairchild, PhD, and his laboratory present novel research related to the biology and potential implications of allograft rejection of CD28 T cells, mediators of graft injury.
  • In the clinical arena, Brian Stephany, MD, reports on the risks for posttransplant acute kidney injury following solid organ transplantation – specifically, the potential for, and predictive value of, renal damage in heart transplant candidates being bridged to transplant using left ventricular assist devices.
  • Stuart M. Flechner, MD, FACS, describes the results of a large multicenter study aimed at evaluating the clinical utility and safety of a new induction therapy for kidney transplant recipients.
  • Using public administrative data,  Jesse D. Schold, PhD, MStat, Med, regularly publishes innovative research related to population outcomes, and in this case, on regulatory entities’ quality oversight and its implications for renal transplant centers and their patients.
  • Finally, Urological & Kidney Institute Chairman Eric A. Klein, MD, provides a summary of our achievements as a kidney transplant program with national and international resources for those in need.

We hope you enjoy learning about our research, which remains patient-centered and focused on the goal of advancing the field of kidney transplantation.